MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive profile of the COPPADIS cohort: Sociodemographic characteristics, lifestyle, neuropsychiatric and non-motor(NM) associated features and potentially treatable variables

A. Horta-Barba, S. Martinez-Horta, H. Bejr-Kasem, B. Pascual-Sedano, J. Pagonabarraga, D. Santos Garcia, T. Deus Fonticoba, S. Jesús, M. Aguilar, LL. Planellas, J. Garcia Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M.A Ávila Rivera, M.J Catalán, L. López Díaz, V. Puente, J.M Garcia Moreno, C. Borrue, B. Solano Vila, M. Alvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J.C Martinez Castrillo, P. Sanchez Alonso, M.G Alonso Losada, N. López Ariztegui, I. Gastón, M. Blazquez Estrada, M. Seijjo, J. Ruiz Martinez, C. Valero, M. Kurtis, O. de Fabregues-Boixar, J. Gonzalez Ardura, C. Prieto Jurczynska, P. Martinez-Martin, P. Mir, J. Kulisevsky, C. study group (Barcelona, Spain)

Meeting: MDS Virtual Congress 2020

Abstract Number: 721

Keywords: Cognitive dysfunction

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To explore the cross-sectional cognitive characteristics of the COPPADIS cohort and to identify associations between cognitive performance and lifestyle, neuropsychiatric symptoms, NM features and potentially treatable factors.

Background: COPPADIS (COhort of Patients with PArkinson’s DIsease in Spain) is an observational, 5-year follow-up,nationwide, multicenter study aimed to elucidate the course of Parkinson’s disease (PD) an to identify biomarkers to predict disease-related complications.

Method: From the cross-sectional database with 694 patients, we selected those with age,disease duration, total LD and DA treatment duration and equivalent daily dose, H&Y stage, UPDRS-III, NM symptoms scale(NMS), Beck Depression Inventory-II(BDI-II),QUIP-RS,PDSS, PDQ-39,MMSE,NPI, and PD-CRS data. We also collected data regarding RBD, falls, freezing, regular cognitive and physical exercise. Blood testing variables were also recorded. Patients with history of anemia or other neurologic disorders were excluded.

Results: A total sample of 533 patients was studied(mean age=62±8;disease duration=5±6;UPDRS-III(off)=22±11;H&Ystage=15%stage1;9%stage1.5;60%stage2,7.1%stage2.5;7.8%stage3,and 1.3 stage4). The PD-CRS classified 393 patients as cognitively preserved(PD-NC),114 as PD-MCI(21%),and 26 as PDD(4.8%).PD-NC were significantly younger than PD-MCI/PDD (p<0.05). All PD-CRS subtests significantly differentiated cognitive groups. The PD-NC group showed better scores in the total NMSS,BDI-II,PDSS,PDQ-39,and NPI dysphoria and apathy. No differences were found in these measures between PD-MCI and PDD. Clinically relevant apathy was found in 21% of PD-NC,35% of PD-MCI and 43% of PDD. Linear regression analysis showed a significant association between cognitive performance and severity of depressive symptoms, homocysteine, B12,and iron levels. Significant differences were found between cognitive groups in the frequency of falls and freezing. Practice of regular exercise and cognitive exercise were both associated with better PD-CRS subcortical score.

Conclusion: In the COPPADIS cohort the prevalence of PD-MCI in early PD patients is similar than previously reported. Early cognitive changes have a significant impact on QoL and are influenced by depressive symptoms,frequency of falls and freezing,regular exercise and cognitive stimulation,and levels of homocysteine, B12, and iron.

To cite this abstract in AMA style:

A. Horta-Barba, S. Martinez-Horta, H. Bejr-Kasem, B. Pascual-Sedano, J. Pagonabarraga, D. Santos Garcia, T. Deus Fonticoba, S. Jesús, M. Aguilar, LL. Planellas, J. Garcia Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M.A Ávila Rivera, M.J Catalán, L. López Díaz, V. Puente, J.M Garcia Moreno, C. Borrue, B. Solano Vila, M. Alvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J.C Martinez Castrillo, P. Sanchez Alonso, M.G Alonso Losada, N. López Ariztegui, I. Gastón, M. Blazquez Estrada, M. Seijjo, J. Ruiz Martinez, C. Valero, M. Kurtis, O. de Fabregues-Boixar, J. Gonzalez Ardura, C. Prieto Jurczynska, P. Martinez-Martin, P. Mir, J. Kulisevsky, C. study group. Cognitive profile of the COPPADIS cohort: Sociodemographic characteristics, lifestyle, neuropsychiatric and non-motor(NM) associated features and potentially treatable variables [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/cognitive-profile-of-the-coppadis-cohort-sociodemographic-characteristics-lifestyle-neuropsychiatric-and-non-motornm-associated-features-and-potentially-treatable-variables/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-profile-of-the-coppadis-cohort-sociodemographic-characteristics-lifestyle-neuropsychiatric-and-non-motornm-associated-features-and-potentially-treatable-variables/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley